Delivery Order SPE2DB22D9239-SPE2DB24FDJ78

Award Date 5/17/24
Potential Completion Date 6/10/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $17,019.84 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4563691587 PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products. This order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, which has a potential value of up to $4,999,999 and enables the agency to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract, valued at $34,039.68, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to $499,999,999, that runs through December 31, 2025. The IDC allows DLA to issue delivery orders for a comprehensive range of pharmaceutical items to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $25,529.76, is for the delivery of 4563651600 - PERJETA 420 MG/14 ML VIAL 14ML. This delivery order is issued under DMS Pharmaceutical Group's broader indefinite delivery contract (IDC) with the DLA, contract 4600082013 under the SPE2DB program, valued up to $4,999,999 through 2025. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a $4,254.96 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 4564220840 - PERJETA 420 MG/14 ML VIAL 14ML, a pharmaceutical product. This order is part of a larger indefinite delivery vehicle (IDV) contract, contract 4600082013 under the SPE2DB program, with a ceiling value of up to $4,999,999 through the end of 2025. This IDV enables DLA to...
The U.S. Department of Defense, through the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract valued at $8,509.92 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4566529142 - PERJETA 420 MG/14 ML VIAL 14ML, a specialized pharmaceutical product, with a performance period through December 12, 2024. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency awarded a firm fixed-price delivery order contract worth $42,549.60 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PERJETA 420 MG/14 ML VIAL 14ML pharmaceutical products, with a completion date of February 15, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract with DLA, valued up to $4,999,999, that enables the agency to issue delivery orders for a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm fixed-price delivery order covers the supply of 4565730524 - PERJETA 420 MG/14 ML VIAL 14ML, with a period of performance through September 26, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $78,783.00 firm fixed-price delivery order is for the supply of 4556749427 PERJETA 420 MG/14 ML VIAL 14ML to support the medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 order is for the supply of PERJETA 420 MG/14 ML VIAL 14ML, with a period of performance through February 22, 2024. This delivery order is issued under DMS Pharmaceutical Group's larger indefinite delivery contract 4600082013 with the Defense Logistics Agency,...
This federal contract award, valued at $12,764.88, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4565242595 PERJETA 420 MG/14 ML VIAL 14ML, with an ultimate completion date of August 12, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDJ78
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,529.76 firm-fixed-price contract is for the delivery of 4564676682 - PERJETA 420 MG/14 ML VIAL 14ML and has a completion date of June 10, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, for the provision of a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. This contract award is not associated with a set-aside program.

Generated 8/16/24, 9:46 AM